In this study, we demonstrate that the necroptotic machinery genes RIPK1, RIPK3, and MLKL are highly expressed in gliomas and positively correlate with disease progression and patient prognosis (Figs. 1 and S1). The gene discussed is MLKL; the disease is central nervous system cancer.